Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

National digital series spotlights evidence-based strategies to achieve type 2 diabetes remission through lifestyle interventions

ACLM (PRNewsfoto/American College of Lifestyle M)

News provided by

American College of Lifestyle Medicine

Mar 30, 2026, 06:00 ET

Share this article

Share toX

Share this article

Share toX

The American College of Lifestyle Medicine and Content With Purpose launch Project Remission: A Lifestyle Medicine Approach to Type 2 Diabetes, a video series featuring short documentaries, expert interviews, and patient stories highlighting the potential of lifestyle medicine to reshape diabetes care.

ST. LOUIS, March 30, 2026 /PRNewswire/ -- The American College of Lifestyle Medicine (ACLM) today announces the launch of Project Remission: A Lifestyle Medicine Approach to Type 2 Diabetes, a national digital film series developed in partnership with Content With Purpose (CWP). Premiering during a live webinar featuring experts in the field at noon CT today, with the full series also launching digitally, the initiative highlights how evidence-based lifestyle medicine can treat and, in many cases, achieve remission of type 2 diabetes (T2D).

Continue Reading
Project Remission: A Lifestyle Medicine Approach to Type 2 Diabetes examines how lifestyle medicine is reshaping clinical practice — addressing root causes of disease through a whole-person, evidence-based approach.
Project Remission: A Lifestyle Medicine Approach to Type 2 Diabetes examines how lifestyle medicine is reshaping clinical practice — addressing root causes of disease through a whole-person, evidence-based approach.
Speed
Speed

At a time when nearly half of U.S. adults are living with diabetes or prediabetes — contributing to $412.9 billion in annual health care costs — the need for scalable, sustainable solutions has never been greater. Lifestyle medicine offers a whole-person, evidence-based clinical framework that addresses the root causes of chronic disease through therapeutic lifestyle interventions.

Lifestyle medicine is a medical specialty that uses therapeutic lifestyle interventions as a primary modality to treat chronic conditions, including, but not limited to, cardiovascular diseases, T2D and obesity. Applying the six pillars of lifestyle medicine — a whole-food, plant-predominant eating pattern, physical activity, restorative sleep, stress management, connectedness and avoidance of risky substances — clinicians are trained to deliver prescriptive, evidence-based lifestyle behavior change to treat, reverse and prevent chronic disease.

Project Remission elevates this standard of care by showcasing clinicians, health systems and organizations who are integrating lifestyle medicine into real-world practice settings. Through short-form documentaries featuring actual patients recounting their health journeys, expert interviews and practical implementation insights, the series demonstrates how appropriately dosed lifestyle interventions can support patients in achieving remission of T2D, which, beyond improving clinical outcomes, improves patient satisfaction and provider well-being, provides cost savings, and advances health equity—the Quintuple Aim.

"Too often, chronic disease like type 2 diabetes is managed as a condition that patients must live with indefinitely," ACLM President Padmaja Patel, MD, DipABLM, FACLM, CPE, said. "At the American College of Lifestyle Medicine, we believe remission—for type 2 diabetes and many other chronic conditions—should be the North Star outcome guiding care. The strong alignment among our partners involved in this project reflects a shared vision of moving beyond symptom control toward health restoration, extended quality of life and a more sustainable future for patients and health systems alike."

By focusing on modifiable risk factors and taking into consideration upstream drivers of health, lifestyle medicine provides a framework for a redesigned, equitable and high-value health care delivery system.

Max Smith, founder and managing director at Content With Purpose, said, "Project Remission reflects the urgency and opportunity before us. We are honored to collaborate with ACLM to spotlight clinicians, health systems, and patients who are demonstrating that remission of type 2 diabetes is achievable through evidence-based lifestyle interventions and how these people's lives are forever improved. These stories show what is possible when we address the root cause of chronic disease and empower both clinicians and patients with practical, science-backed tools."

The series features contributions from partner organizations, including: AdventHealth, Albertsons Companies, Ardmore Institute of Health, Blue Shield of California, Blue Zones Health, Cecelia Health, Cronometer, Hospital for Special Surgery, Keck Graduate Institute, Kellyn, ModifyHealth, My Viva Inc., National Association of Chronic Disease Directors, Point Loma Narazene University, University of Mississippi Medical Center, and USC School of Medicine Greenville.

Leading experts interviewed include:

  • Ed J. Stein, PharmD, MPH, DipACLM, consulting pharmacist, Modern Health Goals
  • Josie Bidwell, DNP, RN, FNP-C, DipACLM, FACLM, professor & clinical director, Department of Preventive Medicine, director, Office of Well-being, University of Mississippi Medical Center
  • Eduardo J. Sanchez, MD, MPH, FAHA, chief medical officer for prevention, American Heart Association
  • Mahima Gulati, MD, DipABLM, FACLM, board-certified endocrinologist, UConn Health
  • Michelle McMacken, MD, FACP, DipABLM, executive director of nutrition and lifestyle medicine, NYC Health + Hospitals
  • Wayne Dysinger, MD, MPH, DipABLM, FACLM, chief medical officer, Blue Zones Health

In addition to highlighting clinical outcomes, Project Remission explores the implementation models making this work possible, including dedicated lifestyle medicine clinics, interprofessional care delivery teams, group visits and reimbursement strategies that support long-term sustainability. The series also includes a dedicated explainer film clarifying the clinical definition of remission in the context of T2D and how it differs from reversal and disease management, ensuring consistency with evidence-based standards. Three in-depth case studies from the Borinquen Medical Center, the LEADR Program and Florida State University further demonstrate how lifestyle medicine is being applied in diverse care settings to support patients in achieving remission. Together, these components reinforce ACLM's commitment to filling the longstanding gap in lifestyle medicine education across pre- and post-professional training.

"As an endocrinologist, I see how exhausting it is for patients to manage chronic disease like type 2 diabetes through escalating medications, side effects, and mounting financial costs," said Mahima Gulati, MD, DipABLM, FACLM, associate professor of medicine at UConn Health. "Project Remission offers something profoundly different— the possibility of addressing root causes and helping patients move toward remission through sustainable lifestyle change. That message is deeply empowering for patients who want to reclaim agency over their health."

Project Remission will be available to stream beginning March 30, 2026, here.

Health professionals, policymakers, employers and members of the public are encouraged to explore the series and learn how evidence-based lifestyle medicine can transform care for individuals living with T2D.

About ACLM

The American College of Lifestyle Medicine (ACLM) is the nation's medical professional society advancing the field of lifestyle medicine as the foundation of a redesigned, value-based and equitable health care delivery system, essential to achieving the Quintuple Aim and whole-person health. ACLM represents, advocates for, trains, certifies, and equips its members to identify and eradicate the root cause of chronic disease by optimizing modifiable risk factors. ACLM is filling the gaping void of lifestyle medicine in medical education, providing more than 1.2 million hours of lifestyle medicine education to physicians and other health professionals since 2004, while also advancing research, clinical practice and reimbursement strategies.

About CWP 

Content With Purpose (CWP) is a strategic content creator that partners with leading member bodies and associations to highlight their industries' contributions to sustainable development. Through compelling storytelling, CWP produces and promotes impactful digital series - featuring short documentaries, interviews, articles, and more - designed to raise awareness, drive change, and promote innovation across key sectors. 

The organisation's mission is to communicate hope, opportunity, and solutions - connecting people with ideas that inspire action and collaboration. 

As a proud B Corp Certified company and a 1% for the Planet Member, CWP is committed to using business as a force for good.

SOURCE American College of Lifestyle Medicine

21%

more press release views with 
Request a Demo

Modal title

Also from this source

New study demonstrates feasibility and safety of deprescribing diabetes medications when lifestyle medicine is integrated into primary care

New study demonstrates feasibility and safety of deprescribing diabetes medications when lifestyle medicine is integrated into primary care

A new research study from the American College of Lifestyle Medicine provides real-world evidence that deprescribing glucose‑lowering medications is...

Lifestyle Medicine Whole Person Health Index closes a critical gap in clinical whole-person care

Lifestyle Medicine Whole Person Health Index closes a critical gap in clinical whole-person care

As whole-person care accelerates across the U.S. health care system, clinicians face a persistent and consequential gap: the lifestyle and upstream...

More Releases From This Source

Explore

Computer & Electronics

Computer & Electronics

Health Care & Hospitals

Health Care & Hospitals

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.